Ignite Creation Date:
2024-05-06 @ 3:32 PM
Last Modification Date:
2024-10-26 @ 1:51 PM
Study NCT ID:
NCT04665713
Status:
COMPLETED
Last Update Posted:
2023-07-18
First Post:
2020-12-07
Brief Title:
Effect of Prevalence of BMI on Efficacy of Herbal Medicines in Girls Sexual Precocity
Sponsor:
Childrens Hospital of Fudan University
Organization:
Childrens Hospital of Fudan University
Study Overview
Official Title:
Effect of Prevalence of Overweight and ObesityBody Mass Index BMI on Efficacy of Herbal MedicinesZiYinXieHuo in Girls Sexual Precocity
Status:
COMPLETED
Status Verified Date:
2023-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Effect of Prevalence of Overweight and ObesityBody Mass Index BMI on Efficacy of herbal medicinesZiYinXieHuo in girls sexual Precocity
Detailed Description:
Herbal medicinesZiYinXieHuo might have implications for the effects of treatment in sexual Precocity among the higher BMI girls Thus the investigator use cohort studies to confirm this hypothesis Selected children were from the precocious puberty clinic of the affiliated Pediatrics Hospital of Fudan University Calculated according to the sample size sample 6 the total number of cases was 192 All cases met the selected criteria The subjects were divided into three groups according to the cut-off point of BMI of height and weight of Chinese children and adolescents girls age in 2-18 Compared with children of the same age and sex overweight group includes those BMI in the range of P85-P95 obese group includes those BMI greater than or equal to P95 and the girls whose BMI in the range of P5-P85 are assigned to the normal group Chinese herbs for ZiYinXieHuo were used to treat girls with precocious puberty only given by hospital preparation drug dose 30mlonce 3 times a day A course of treatment lasts for three months In this study two courses of treatment 6 months were observed The subjects would received three examinations before taking the drug baseline the third month metaphase and the sixth month end point
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None